分组 | 非难治性GD组 (n = 66) | 难治性GD组 (n = 262) | P值 |
发病年龄(岁) | 38 (27~48) | 34 (25~47) | 0.779 |
性别(男/女) | 8/58 | 67/195 | 0.002 |
BMI (kg/m2) | 21.8 ± 2.6 | 22.4 ± 3.5 | 0.215 |
家族史(%) | 5 (7.6) | 35 (13.4) | 0.199 |
吸烟史(%) | 6 (9.1) | 41 (15.6) | 0.174 |
饮酒史(%) | 3 (4.5) | 27 (10.3) | 0.147 |
合并自身免疫性疾病(%) | 5 (7.6) | 15 (5.7) | 0.574 |
TSH (uIU/ml) IQR | 0.005 (0.005~0.005) | 0.005 (0.005~0.005) | 0.275 |
FT3 (pmol/l) IQR | 13.8 (8.6~24.7) | 20.7 (11.9~38.2) | 0.001 |
FT4 (pmol/l) IQR | 38.5 (26.1~60.6) | 57.5 (35.6~100.0) | <0.001 |
TRAB (IU/l) IQR | 6.1 (3.5~16.2) | 11.5 (6.0~23.3) | 0.005 |
TGAb (IU/mL) IQR | 230.9 (74.73~1004.4) | 232.8 (42.7~639.7) | 0.382 |
TGAB阳性率(%) | 29 (43.9) | 111 (42.4) | 0.817 |
TPOAb (IU/mL) IQR | 265.7 (47.3~439.3) | 259.6 (92.0~497.6) | 0.498 |
TPOAB阳性率(%) | 30 (45.5) | 157 (59.9) | 0.034 |
甲状腺I度肿大(%) | 9 (13.6) | 71 (27.2) | 0.002 |
II度肿大及以上肿大(%) | 2 (3) | 31 (11.9) | - |
眼征(%) | 12 (18.2) | 61 (23.3) | 0.373 |